What Researchers Did
Researchers conducted a prospective randomized open-label study comparing hyperbaric oxygen therapy (HBOT) plus conventional medical treatment to conventional treatment alone for patients experiencing a severe attack of ulcerative colitis.
What They Found
The study found no statistically significant differences between the HBOT group and the conventional treatment alone group in clinical outcome, laboratory tests, fecal weight, or health-related quality of life. There was also no difference in colectomy rates or safety profiles between the two groups.
What This Means for Canadian Patients
For Canadian patients experiencing a severe attack of ulcerative colitis, this study suggests that adding hyperbaric oxygen therapy to standard medical treatment does not offer additional benefits. Therefore, current conventional therapies remain the primary recommended approach for managing severe ulcerative colitis.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
A potential limitation of this open-label study is the lack of blinding, which could influence subjective outcome assessments.